Spot Ethereum ETF Launch Date Possibly On July 2: Bloomberg Analyst
Bloomberg ETF analyst Eric Balchunas moved up the launch date for the highly anticipated spot Ether ETF to July 2.
‘Nvidia Is Sucking The Oxygen Out Of The Room:’ Wealth Manager Says Stocks With ‘Good Fundamental Execution’ Can Still Decline Because Of AI Stalwart
Nvidia is second-best performer among S&P 500 stocks, thanks to its AI exposure, and the strength is expected to last multiple years.
Adidas Faces Bribery Allegations In China, Launches Investigation: Report
Adidas AG is reportedly probing deep into accusations of bribery within its China operations, following whistleblower allegations of high-ranking officials embezzling millions. Despite the severity, no staff have been suspended as Adidas reassures its commitment to high ethical standards.
AstraZeneca Says Calquence/Chemo Combo Data Shows Additional 16.8 Months Without Disease Progression In Patients With Certain Type Of Blood Cancer
AstraZeneca shares data from the ECHO Phase 3 trial on Calquence plus bendamustine and rituximab in untreated mantle cell lymphoma patients over 65.
S&P 500 Index Year-End Target Raised To 5,600 By Goldman Sachs On Strong Tech Earnings And Valuation Expansion
Goldman Sachs Group has revised its year-end target for the S&P 500 Index to 5,600, up from the previous 5,200. The adjustment is attributed to the robust earnings growth of five major U.S. tech companies and an increased fair value price-to-earnings ratio.
Now Listen To Webpages Using Google Chrome Browser In Two Simple Steps: Here’s How
Google adds feature to Chrome browser, Listen to this page, allowing playback controls for multiple languages. Direct competitor to Apple's Siri feature in Safari app.
Lennar, La-Z-Boy And 3 Stocks To Watch Heading Into Monday
US stock futures mixed, Lennar reports lower Q2 earnings, Northfield Bancorp approves stock repurchase, La-Z-Boy and Quantum post earnings.
Investor Optimism Continues To Wane Despite Nasdaq’s Fifth Consecutive Record Close On Friday
The CNN Business Fear & Greed Index measures market sentiment, with 38.4 reading on Friday in the Fear zone.
EXCLUSIVE: Femasys At Inflection Point And Undervalued, Expects Growth Potential Following Roe v. Wade Overturn, CEO Says
Femasys focuses on innovative women's healthcare solutions. Their FemBloc product, a non-surgical permanent birth control, is in late-stage development, aiming for a $20 billion market.